Main content area

Effect of <em>Bifidobacterium breve</em> on the Intestinal Microbiota of Coeliac Children on a Gluten Free Diet: A Pilot Study

Quagliariello, Andrea, Aloisio, Irene, Bozzi Cionci, Nicole, Luiselli, Donata, D’Auria, Giuseppe, Martinez-Priego, Llúcia, Pérez-Villarroya, David, Langerholc, Tomaž, Primec, Maša, Mičetić-Turk, Dušanka, Di Gioia, Diana
Nutrients 2016 v.8 no.10
Bacteroides fragilis, Bifidobacterium breve, Clostridium, DNA, Euryarchaeota, Lactobacillus brevis, anti-inflammatory activity, celiac disease, children, dietary supplements, feces, genes, gliadin, gluten-free foods, intestinal microorganisms, intestines, peptides, placebos, probiotics, quantitative polymerase chain reaction, ribosomal RNA, taxonomy, toxicity
Coeliac disease (CD) is associated with alterations of the intestinal microbiota. Although several Bifidobacterium strains showed anti-inflammatory activity and prevention of toxic gliadin peptides generation in vitro, few data are available on their efficacy when administered to CD subjects. This study evaluated the effect of administration for three months of a food supplement based on two Bifidobacterium breve strains (B632 and BR03) to restore the gut microbial balance in coeliac children on a gluten free diet (GFD). Microbial DNA was extracted from faeces of 40 coeliac children before and after probiotic or placebo administration and 16 healthy children (Control group). Sequencing of the amplified V3-V4 hypervariable region of 16S rRNA gene as well as qPCR of Bidobacterium spp., Lactobacillus spp., Bacteroides fragilis group Clostridium sensu stricto and enterobacteria were performed. The comparison between CD subjects and Control group revealed an alteration in the intestinal microbial composition of coeliacs mainly characterized by a reduction of the Firmicutes/Bacteroidetes ratio, of Actinobacteria and Euryarchaeota. Regarding the effects of the probiotic, an increase of Actinobacteria was found as well as a re-establishment of the physiological Firmicutes/Bacteroidetes ratio. Therefore, a three-month administration of B. breve strains helps in restoring the healthy percentage of main microbial components.